Information Technology·Application Software·$6.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-4.51 | N/A | -9922.22% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-4.51 | N/A | -9922.22% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current market conditions. They highlighted the importance of adapting strategies to navigate the challenges ahead.
Management acknowledged the challenges faced in the quarter.
They emphasized the need for strategic adjustments moving forward.
Core Scientific's significant EPS miss indicates ongoing financial struggles. Despite this, the stock saw a slight increase of 1.13%, likely driven by investor sentiment or external market factors rather than the earnings results. The lack of revenue data and guidance leaves uncertainty about the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERICAN HEALTHCARE REIT
Aug 5, 2024